Massive study probes which diabetes pill best protects the heart after an attack
NCT ID NCT07198191
Summary
This study looks at which of two common types of diabetes medicine is better at preventing major heart problems in people who have both diabetes and a recent heart attack. Researchers will analyze the health records of 200,000 patients in Korea to compare outcomes for those taking SGLT2 inhibitors versus those taking DPP4 inhibitors. The goal is to provide real-world evidence to help doctors choose the safest and most effective medication for this high-risk group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Yongin Severance Hospital, Yonsei University Health System
Yongin, Gyeonggi-do, 16995, South Korea
Conditions
Explore the condition pages connected to this study.